Please login to the form below

Not currently logged in
Email:
Password:

Gambro

This page shows the latest Gambro news and features for those working in and with pharma, biotech and healthcare.

Baxter to launch HyQvia in US next week

Baxter to launch HyQvia in US next week

which is due to complete by the middle of next year - and costs associated with its 2013 acquisition of medical technology firm Gambro.

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Pharma deals during March 2014 Pharma deals during March 2014

    This business combines renal dialysis company Gambro which Baxter recently acquired for $4bn.

  • Pharma deals during December 2012 Pharma deals during December 2012

    The highest value deal this month is Baxter's purchase of Gambro at $4bn representing 2.5 x 2011 sales. ... Gambro, which has been privately owned since 2006, sells haemodialysis equipment which will complement Baxter's presence in peritoneal dialysis

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical education website. Support...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....